NCT06381986View on ClinicalTrials.gov

Efficacy and Safety of SHJ002 Ophthalmic Solution in the Treatment of Corneal Erosion in Sjogren's Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

June 28, 2024

Primary Completion Date

April 10, 2025

Study Completion Date

April 17, 2025

Conditions
Corneal Erosion
Interventions
DRUG

SHJ002

Topical ophthalmic

OTHER

Vehicle

Topical ophthalmic

Trial Locations (6)

106

Cathay General Hospital, Taipei

236

Chang Gung Memorial Hospital-Tu Cheng, New Taipei City

807

Kaohsiung Medical Chung-Ho Memorial Hospital, Kaohsiung City

10449

MacKay Memorial Hospital, Taipei

11490

Tri-Service General Hospital, Taipei

81341

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
lead

Sunhawk Vision Biotech, Inc.

INDUSTRY

NCT06381986 - Efficacy and Safety of SHJ002 Ophthalmic Solution in the Treatment of Corneal Erosion in Sjogren's Patients | Biotech Hunter | Biotech Hunter